- Home
- YOSH vs CELZ Comparison
YOSH vs CELZ Comparison
Compare YOSH & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOSH
- CELZ
- Stock Information
- Founded
- YOSH 2016
- CELZ 1998
- Country
- YOSH United States
- CELZ United States
- Employees
- YOSH N/A
- CELZ N/A
- Industry
- YOSH Restaurants
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- YOSH Consumer Discretionary
- CELZ Health Care
- Exchange
- YOSH Nasdaq
- CELZ Nasdaq
- Market Cap
- YOSH 5.0M
- CELZ 4.4M
- IPO Year
- YOSH 2022
- CELZ N/A
- Fundamental
- Price
- YOSH $8.76
- CELZ $5.40
- Analyst Decision
- YOSH
- CELZ
- Analyst Count
- YOSH 0
- CELZ 0
- Target Price
- YOSH N/A
- CELZ N/A
- AVG Volume (30 Days)
- YOSH 187.8K
- CELZ 139.9K
- Earning Date
- YOSH 03-31-2025
- CELZ 03-21-2025
- Dividend Yield
- YOSH N/A
- CELZ N/A
- EPS Growth
- YOSH N/A
- CELZ N/A
- EPS
- YOSH N/A
- CELZ N/A
- Revenue
- YOSH $11,652,880.00
- CELZ $11,000.00
- Revenue This Year
- YOSH N/A
- CELZ N/A
- Revenue Next Year
- YOSH N/A
- CELZ N/A
- P/E Ratio
- YOSH N/A
- CELZ N/A
- Revenue Growth
- YOSH 25.97
- CELZ N/A
- 52 Week Low
- YOSH $2.71
- CELZ $1.96
- 52 Week High
- YOSH $16.50
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- YOSH 54.11
- CELZ 69.61
- Support Level
- YOSH $3.83
- CELZ $4.50
- Resistance Level
- YOSH $16.50
- CELZ $6.90
- Average True Range (ATR)
- YOSH 2.79
- CELZ 0.76
- MACD
- YOSH 0.29
- CELZ 0.19
- Stochastic Oscillator
- YOSH 41.36
- CELZ 60.53
About YOSH Yoshiharu Global Co.
Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.